Elizabeth Forminard - 17 Oct 2022 Form 3 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Executive VP, General Counsel
Signature
Raavi Deol, as attorney-in-fact for Elizabeth Forminard
Issuer symbol
JNJ
Transactions as of
17 Oct 2022
Net transactions value
$0
Form type
3
Filing time
26 Oct 2022, 16:47:36 UTC
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JNJ Common Stock 3,211 17 Oct 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 11,521 $115.67 Direct F1
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 8,921 $129.51 Direct F1
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 9,344 $131.94 Direct F1
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 13,072 $151.41 Direct F1
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 10,756 $164.62 Direct F1
holding JNJ Employee Stock Options (Right to Buy) 17 Oct 2022 Common Stock 8,401 $165.89 Direct F1
holding JNJ Restricted Share Units 17 Oct 2022 Common Stock 979 Direct F2
holding JNJ Restricted Share Units 17 Oct 2022 Common Stock 1,022 Direct F2
holding JNJ Restricted Share Units 17 Oct 2022 Common Stock 851 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vested and exercisable on the third anniversary of the date of the grant.
F2 Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:

forminardpoa1.txt